Otonomy Added to NASDAQ Biotechnology Index

Back to Jobs

SAN DIEGO , Dec. 15, 2015 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced that the company has been selected for addition to the NASDAQ

Apply Now